THCNYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31

TENET HEALTHCARE CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026

$266.39−0.86 (-0.32%)

Close on Oct 19, 2026

Market cap: $22.37B
P/E (TTM): 10.3
Dividend yield: –

TENET HEALTHCARE CORP income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31
Revenue	21,310	20,675	20,564	19,174	19,485	17,640	18,479	18,313	19,179	19,621	–	–	–	–	–	–	–	–
Operating Income	3,508	5,956	2,510	2,333	2,871	1,989	1,537	1,637	1,113	1,247	1,077	925	663	749	653	634	538	311
Interest Expense	821	826	901	890	923	1,003	985	1,004	1,028	979	912	754	474	412	375	424	445	418
Income from Equity Investments	264	260	228	216	218	169	175	150	144	131	99	12	15	8.00	8.00	5.00	–	–
Other Non-Operating Income	117	126	19	11	14	1.00	-5.00	-5.00	–	–	–	–	–	–	–	–	–	–
Merger & Restructuring Charges	44	56	79	118	57	184	137	115	117	202	318	3.00	16	19	20	-1.00	7.00	16
Asset Impairment Charges	61	7.00	43	94	8.00	92	42	77	402	14	19	20	12	3.00	6.00	10	–	–
Gain (Loss) on Investments	–	–	–	–	–	–	–	–	–	8.00	1.00	–	1.00	1.00	3.00	5.00	0	22
Gain (Loss) on Sale of Assets	4.00	4.00	29	117	23	25	–	–	–	–	–	–	–	–	–	–	–	–
Legal Settlements	-64	-35	-47	-70	-116	-44	-141	-38	-23	-293	-291	-25	-31	-5.00	-55	-12	-31	-41
Pretax Income	2,800	5,248	1,617	1,345	1,888	671	320	629	-101	248	144	147	-158	334	164	158	205	–
Income Tax Expense	433	1,184	306	344	411	-97	160	173	219	67	68	49	-65	125	61	-977	-23	-25
Income from Continuing Operations	1,407	3,200	611	410	915	399	-226	101	-704	-187	-142	34	-123	185	68	1,101	212	73
Income from Discontinued Operations	–	–	0	1.00	-1.00	0	11	3.00	0	-5.00	2.00	-22	-11	-76	-9.00	17	-31	-47
Net Income incl. Noncontrolling Interests	2,367	4,064	1,311	1,001	1,476	768	171	459	-320	176	78	76	-104	133	94	1,152	197	32
Minority Interest in Earnings	960	864	700	590	562	369	386	355	384	368	218	64	30	–	12	9.00	10	7.00
Net Income	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1,119	181	25
Preferred Dividends	–	–	–	–	–	–	–	–	–	–	–	–	0	11	24	24	6.00	–
Net Income to Common	1,407	3,200	611	411	914	399	-215	104	-704	-192	-140	12	-134	141	58	1,119	181	–
EPS (Basic)(per share)	15.61	33.02	6.01	3.84	8.55	3.80	-2.08	1.02	-7.00	-1.93	-1.41	0.12	-1.32	1.35	0.49	9.24	1.52	0.20
EPS (Diluted)(per share)	15.49	32.70	5.71	3.79	8.42	3.75	-2.08	1.00	-7.00	-1.93	-1.41	0.12	-1.32	1.30	0.48	8.16	1.48	0.20
Shares Outstanding (Basic, Weighted)(shares)	90	97	102	107	107	105	103	102	101	99	99	98	102	104	117	121	120	119
Shares Outstanding (Diluted, Weighted)(shares)	91	98	105	111	109	106	103	104	101	99	99	100	102	109	121	140	127	120
EBITDA	4,371	6,774	3,380	3,174	3,726	2,846	2,387	2,439	1,983	2,097	1,874	1,774	1,208	1,179	1,051	1,014	924	682

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: 20.8%
Net margin: –
Return on equity, FY2025: –

Financial strength

Current ratio: 1.41
Debt to equity: 2.84
Debt to assets: 43.2%
Cash to current liabilities: 39.0%

Valuation

P/E ratio: 10.3
Price to sales: 1.03
Price to book: 4.80
Dividend yield: –